Previous studies have reported this miR to be downregulated in esophageal cancer[43] and upregulated in colorectal cancer and breast cancer.[44,45] miR-454 has been reported to function as an oncogenic miR by targeting PTEN. The gene discussed is PTEN; the disease is breast carcinoma.